Search | VHL Search Portal

1.

Current outstanding challenges in germ cell tumors.

Salous, Tareq; Adra, Nabil.

Curr Opin Oncol ; 36(3): 169-173, 2024 May 01.

Article in English | MEDLINE | ID: mdl-38573206

2.

Prostate Cancer, Version 3.2024.

Schaeffer, Edward M; Srinivas, Sandy; Adra, Nabil; An, Yi; Bitting, Rhonda; Chapin, Brian; Cheng, Heather H; D'Amico, Anthony Victor; Desai, Neil; Dorff, Tanya; Eastham, James A; Farrington, Thomas A; Gao, Xin; Gupta, Shilpa; Guzzo, Thomas; Ippolito, Joseph E; Karnes, R Jeffrey; Kuettel, Michael R; Lang, Joshua M; Lotan, Tamara; McKay, Rana R; Morgan, Todd; Pow-Sang, Julio M; Reiter, Robert; Roach, Mack; Robin, Tyler; Rosenfeld, Stan; Shabsigh, Ahmad; Spratt, Daniel; Szmulewitz, Russell; Teply, Benjamin A; Tward, Jonathan; Valicenti, Richard; Wong, Jessica Karen; Snedeker, Jenna; Freedman-Cass, Deborah A.

J Natl Compr Canc Netw ; 22(3): 140-150, 2024 04.

Article in English | MEDLINE | ID: mdl-38626801

3.

Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer.

Su, Christopher T; Nizialek, Emily; Berchuck, Jacob E; Vlachostergios, Panagiotis J; Ashkar, Ryan; Sokolova, Alexandra; Barata, Pedro C; Aggarwal, Rahul R; McKay, Rana R; Agarwal, Neeraj; McClure, Heather M; Nafissi, Nellie; Bryce, Alan H; Sartor, Oliver; Sayegh, Nicolas; Cheng, Heather H; Adra, Nabil; Sternberg, Cora N; Taplin, Mary-Ellen; Cieslik, Marcin; Alva, Ajjai S; Antonarakis, Emmanuel S.

Prostate ; 83(3): 227-236, 2023 02.

Article in English | MEDLINE | ID: mdl-36382533

4.

Challenges in the management of relapsed germ cell tumors.

Salous, Tareq; Adra, Nabil.

Curr Opin Oncol ; 35(3): 218-223, 2023 05 01.

Article in English | MEDLINE | ID: mdl-36966503

5.

Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology.

Schaeffer, Edward M; Srinivas, Sandy; Adra, Nabil; An, Yi; Barocas, Daniel; Bitting, Rhonda; Bryce, Alan; Chapin, Brian; Cheng, Heather H; D'Amico, Anthony Victor; Desai, Neil; Dorff, Tanya; Eastham, James A; Farrington, Thomas A; Gao, Xin; Gupta, Shilpa; Guzzo, Thomas; Ippolito, Joseph E; Kuettel, Michael R; Lang, Joshua M; Lotan, Tamara; McKay, Rana R; Morgan, Todd; Netto, George; Pow-Sang, Julio M; Reiter, Robert; Roach, Mack; Robin, Tyler; Rosenfeld, Stan; Shabsigh, Ahmad; Spratt, Daniel; Teply, Benjamin A; Tward, Jonathan; Valicenti, Richard; Wong, Jessica Karen; Shead, Dorothy A; Snedeker, Jenna; Freedman-Cass, Deborah A.

J Natl Compr Canc Netw ; 21(10): 1067-1096, 2023 10.

Article in English | MEDLINE | ID: mdl-37856213

6.

Surveillance after Complete Response to First-Line Chemotherapy in Patients with Metastatic Nonseminomatous Germ Cell Tumor.

King, Jennifer M; Althouse, Sandra; Cary, Clint; Masterson, Timothy; Foster, Richard S; Ashkar, Ryan; Hanna, Nasser H; Einhorn, Lawrence H; Adra, Nabil.

J Urol ; 208(3): 641-649, 2022 09.

Article in English | MEDLINE | ID: mdl-35674780

7.

A phase II study assessing the safety and efficacy of ASP1650 in male patients with relapsed refractory germ cell tumors.

Adra, Nabil; Vaughn, David J; Einhorn, Lawrence H; Hanna, Nasser H; Funt, Samuel A; Rosales, Matt; Arozullah, Ahsan; Feldman, Darren R.

Invest New Drugs ; 40(5): 1087-1094, 2022 Oct.

Article in English | MEDLINE | ID: mdl-35759134

8.

NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.

Schaeffer, Edward M; Srinivas, Sandy; Adra, Nabil; An, Yi; Barocas, Daniel; Bitting, Rhonda; Bryce, Alan; Chapin, Brian; Cheng, Heather H; D'Amico, Anthony Victor; Desai, Neil; Dorff, Tanya; Eastham, James A; Farrington, Thomas A; Gao, Xin; Gupta, Shilpa; Guzzo, Thomas; Ippolito, Joseph E; Kuettel, Michael R; Lang, Joshua M; Lotan, Tamara; McKay, Rana R; Morgan, Todd; Netto, George; Pow-Sang, Julio M; Reiter, Robert; Roach, Mack; Robin, Tyler; Rosenfeld, Stan; Shabsigh, Ahmad; Spratt, Daniel; Teply, Benjamin A; Tward, Jonathan; Valicenti, Richard; Wong, Jessica Karen; Berardi, Ryan A; Shead, Dorothy A; Freedman-Cass, Deborah A.

J Natl Compr Canc Netw ; 20(12): 1288-1298, 2022 12.

Article in English | MEDLINE | ID: mdl-36509074

9.

Relations of perceived injustice to psycho-spiritual outcomes in advanced lung and prostate cancer: Examining the role of acceptance and meaning making.

Secinti, Ekin; Wu, Wei; Krueger, Ellen F; Hirsh, Adam T; Torke, Alexia M; Hanna, Nasser H; Adra, Nabil; Durm, Gregory A; Einhorn, Lawrence; Pili, Roberto; Jalal, Shadia I; Mosher, Catherine E.

Psychooncology ; 31(12): 2177-2184, 2022 12.

Article in English | MEDLINE | ID: mdl-36336876

10.

Current Status of Stem Cell Transplant in Treatment of Testicular Germ Cell Tumors.

King, Jennifer; Adra, Nabil.

Curr Oncol Rep ; 24(3): 303-310, 2022 03.

Article in English | MEDLINE | ID: mdl-35113353

11.

Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high-dose chemotherapy and peripheral blood stem cell transplantation.

Agrawal, Vaibhav; Abonour, Rafat; Abu Zaid, Mohammad; Althouse, Sandra K; Ashkar, Ryan; Albany, Costantine; Hanna, Nasser H; Einhorn, Lawrence H; Adra, Nabil.

Cancer ; 127(20): 3751-3760, 2021 10 15.

Article in English | MEDLINE | ID: mdl-34260067

12.

Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer.

Sena, Laura A; Fountain, Julia; Isaacsson Velho, Pedro; Lim, Su Jin; Wang, Hao; Nizialek, Emily; Rathi, Nityam; Nussenzveig, Roberto; Maughan, Benjamin L; Velez, Miguel Gonzalez; Ashkar, Ryan; Larson, Amanda C; Pritchard, Colin C; Adra, Nabil; Bryce, Alan H; Agarwal, Neeraj; Pardoll, Drew M; Eshleman, James R; Lotan, Tamara L; Antonarakis, Emmanuel S.

Oncologist ; 26(2): e270-e278, 2021 02.

Article in English | MEDLINE | ID: mdl-33215787

13.

Pearls and perils in the management of germ cell tumors.

Wei, Cynthia X; Einhorn, Lawrence H; Adra, Nabil.

Curr Opin Oncol ; 33(3): 206-211, 2021 05 01.

Article in English | MEDLINE | ID: mdl-33577208

14.

Percentage of Teratoma in Orchiectomy and Risk of Retroperitoneal Teratoma at the Time of Postchemotherapy Retroperitoneal Lymph Node Dissection in Germ Cell Tumors.

Calaway, Adam C; Kern, Sean Q; Crook, David; Tong, Yan; Masterson, Timothy A; Adra, Nabil; Einhorn, Lawrence H; Foster, Richard S; Cary, Clint.

J Urol ; 206(6): 1430-1437, 2021 12.

Article in English | MEDLINE | ID: mdl-34288715

15.

Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors.

Ashkar, Ryan; Feldman, Darren R; Adra, Nabil; Zaid, Mohammad Abu; Funt, Samuel A; Althouse, Sandra K; Perkins, Susan M; Snow, Christin I; Lazzara, Kayla M; Sego, Lina M; Quinn, David I; Hanna, Nasser H; Einhorn, Lawrence H; Albany, Costantine.

Invest New Drugs ; 39(6): 1656-1663, 2021 12.

Article in English | MEDLINE | ID: mdl-34031784

16.

Structural variation and fusion detection using targeted sequencing data from circulating cell free DNA.

Gawronski, Alexander R; Lin, Yen-Yi; McConeghy, Brian; LeBihan, Stephane; Asghari, Hossein; Koçkan, Can; Orabi, Baraa; Adra, Nabil; Pili, Roberto; Collins, Colin C; Sahinalp, S Cenk; Hach, Faraz.

Nucleic Acids Res ; 47(7): e38, 2019 04 23.

Article in English | MEDLINE | ID: mdl-30759232

17.

High-dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastases.

Kalra, Maitri; Adra, Nabil; Hanna, Nasser; Abonour, Rafat; Einhorn, Lawrence H.

Cancer ; 126(6): 1202-1207, 2020 03 15.

Article in English | MEDLINE | ID: mdl-31743434

18.

Management of residual disease after chemotherapy in germ cell tumors.

King, Jennifer; Adra, Nabil; Einhorn, Lawrence H.

Curr Opin Oncol ; 32(3): 250-255, 2020 05.

Article in English | MEDLINE | ID: mdl-32168037

19.

Long-Term Oncologic Outcomes after Primary Retroperitoneal Lymph Node Dissection: Minimizing the Need for Adjuvant Chemotherapy.

Douglawi, Antoin; Calaway, Adam; Tachibana, Isamu; Panizzutti Barboza, Marcelo; Speir, Ryan; Masterson, Timothy; Adra, Nabil; Foster, Richard; Einhorn, Lawrence; Cary, Clint.

J Urol ; 204(1): 96-103, 2020 Jul.

Article in English | MEDLINE | ID: mdl-32003612

20.

Phase I study of the mTOR inhibitor everolimus in combination with the histone deacetylase inhibitor panobinostat in patients with advanced clear cell renal cell carcinoma.

Wood, Anthony; George, Saby; Adra, Nabil; Chintala, Sreenivasulu; Damayanti, Nur; Pili, Roberto.

Invest New Drugs ; 38(4): 1108-1116, 2020 08.

Article in English | MEDLINE | ID: mdl-31654285

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export: